These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 20963321)

  • 1. HIV-1 genotypic resistance profile of patients failing antiretroviral therapy in Paraná, Brazil.
    Toledo PV; Carvalho DS; Romagnoli L; Marcinko G; Cunha CA; Souza MN; Brindeiro R; Queiroz-Telles Fd
    Braz J Infect Dis; 2010; 14(4):360-71. PubMed ID: 20963321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic diversity of human immunodeficiency virus-1 isolates in Paraná, Brazil.
    Toledo PV; Carvalho DS; Rossi SG; Brindeiro R; de Queiroz-Telles F
    Braz J Infect Dis; 2010; 14(3):230-6. PubMed ID: 20835505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human immunodeficiency virus type 1 (HIV-1) genotyping in Rio de Janeiro, Brazil: assessing subtype and drug-resistance associated mutations in HIV-1 infected individuals failing highly active antiretroviral therapy.
    Couto-Fernandez JC; Silva-de-Jesus C; Veloso VG; Rachid M; Gracie RS; Chequer-Fernandez SL; Oliveira SM; Arakaki-Sanchez D; Chequer PJ; Morgado MG
    Mem Inst Oswaldo Cruz; 2005 Feb; 100(1):73-8. PubMed ID: 15867968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the genotypic pattern of HIV-1 resistance in AIDS patients failing antiretroviral therapy.
    Bahia F; Pedroso C; Netto EM; Figueiredo R; Pinto Neto L; Brites C
    Braz J Infect Dis; 2004 Aug; 8(4):281-9. PubMed ID: 15565258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiretroviral resistance in individuals presenting therapeutic failure and subtypes of the human immunodeficiency virus type 1 in the Northeast Region of Brazil.
    Cavalcanti AM; Lacerda HR; Brito AM; Pereira S; Medeiros D; Oliveira S
    Mem Inst Oswaldo Cruz; 2007 Nov; 102(7):785-92. PubMed ID: 17992369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of resistance-associated mutations in human immunodeficiency virus type 1-positive individuals failing HAART in Rio de Janeiro, Brazil.
    Varella RB; Ferreira SB; Castro MB; Tavares MD; Zalis MG
    Braz J Infect Dis; 2008 Oct; 12(5):380-4. PubMed ID: 19219276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of HIV- type 1 protease and reverse transcriptase in Brazilian children failing highly active antiretroviral therapy (HAART).
    Machado DM; Fernandes SC; Succi RC; Freire WS; Pannuti CS; Gouveia AB; Levi JE; Diaz RS
    Rev Inst Med Trop Sao Paulo; 2005; 47(1):1-5. PubMed ID: 15729467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genotype testing and antiretroviral resistance profiles from HIV-1 patients experiencing therapeutic failure in northeast Brazil.
    Medeiros MS; Arruda EA; Guerrant RL; Brown C; Hammarskjold ML; Rekosh D; Lima AA
    Braz J Infect Dis; 2007 Aug; 11(4):390-4. PubMed ID: 17873990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 reverse transcriptase and protease resistance mutations selected during 16-72 weeks of therapy in isolates from antiretroviral therapy-experienced patients receiving abacavir/efavirenz/amprenavir in the CNA2007 study.
    Ait-Khaled M; Rakik A; Griffin P; Stone C; Richards N; Thomas D; Falloon J; Tisdale M;
    Antivir Ther; 2003 Apr; 8(2):111-20. PubMed ID: 12741623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing subtypes and drug resistance mutations among HIV-1 infected children who failed antiretroviral therapy in Kelantan, Malaysia.
    Mohamad S; Deris ZZ; Yusoff NK; Ariffin TA; Shueb RH
    Braz J Infect Dis; 2012; 16(3):284-8. PubMed ID: 22729198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of resistance mutations to antiretroviral drugs in extensively treated HIV-1-infected patients with failure of highly active antiretroviral therapy.
    Rousseau MN; Vergne L; Montes B; Peeters M; Reynes J; Delaporte E; Segondy M
    J Acquir Immune Defic Syndr; 2001 Jan; 26(1):36-43. PubMed ID: 11176267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human immunodeficiency virus type 1 infection in Oman: antiretroviral therapy and frequencies of drug resistance mutations.
    Al Dhahry SH; Scrimgeour EM; Al Suwaid AR; Al Lawati MR; El Khatim HS; Al Kobaisi MF; Merigan TC
    AIDS Res Hum Retroviruses; 2004 Nov; 20(11):1166-72. PubMed ID: 15588338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistence of genotypic resistance to nelfinavir among women exposed to prophylactic antiretroviral therapy during pregnancy.
    Kakehasi FM; Tupinambás U; Cleto S; Aleixo A; Lin E; Melo VH; Aguiar RA; Pinto JA
    AIDS Res Hum Retroviruses; 2007 Dec; 23(12):1515-20. PubMed ID: 18160009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug resistant mutations detected by genotypic drug resistance testing in patients failing therapy in clade C HIV-1 infected individuals from India.
    Kandathil AJ; Kannangai R; Verghese VP; Pulimood SA; Rupali P; Sridharan G; Grant P; Pillay D; Abraham OC
    Indian J Med Microbiol; 2009; 27(3):231-6. PubMed ID: 19584504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for differences in the sexual transmission efficiency of HIV strains with distinct drug resistance genotypes.
    de Mendoza C; Rodriguez C; Corral A; del Romero J; Gallego O; Soriano V
    Clin Infect Dis; 2004 Oct; 39(8):1231-8. PubMed ID: 15486849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiretroviral resistance mutations in human immunodeficiency virus type 1 infected patients enrolled in genotype testing at the Central Public Health Laboratory, São Paulo, Brazil: preliminary results.
    Rodrigues R; Vazquez CM; Colares JK; Custodio RM; Bonásser Filho F; Souza Ldo R; Gianna MC; Marques CC; Brígido LF
    Mem Inst Oswaldo Cruz; 2005 Feb; 100(1):97-102. PubMed ID: 15867972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 subtype C reverse transcriptase and protease genotypes in Zimbabwean patients failing antiretroviral therapy.
    Kantor R; Zijenah LS; Shafer RW; Mutetwa S; Johnston E; Lloyd R; von Lieven A; Israelski D; Katzenstein DA
    AIDS Res Hum Retroviruses; 2002 Dec; 18(18):1407-13. PubMed ID: 12512512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of the number of failed therapeutic regimes on the development of resistance mutations to HIV-1 in northeast Brazil.
    Medeiros MS; Arruda EA; Guerrant RL; Brown CC; Lima AA
    Braz J Infect Dis; 2007 Oct; 11(5):451-5. PubMed ID: 17962868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergence and genetic evolution of HIV-1 variants with mutations conferring resistance to multiple reverse transcriptase and protease inhibitors.
    Cabana M; Clotet B; Martínez MA
    J Med Virol; 1999 Dec; 59(4):480-90. PubMed ID: 10534730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.